human interferon-lambda

Also Known As:

interferon-lambda, human; IFN-lambda, human; IFN-lambda-1 protein, human; IFN-lambda-2 protein, human; IFN-lambda-3 protein, human; IFNL1 protein, human; IFNL2 protein, human; IFNL3 protein, human; IL-28A protein, human; IL-28B protein, human; IL-29 protein, human; IL28A protein, human; IL28B protein, human; IL29 protein, human; Interferon lambda-1 protein, human; Interferon lambda-2 protein, human; Interferon lambda-3 protein, human; interleukin 28A (interferon, lambda 2) protein, human; interleukin 28A protein, human; interleukin 28A, human; interleukin 28B (interferon, lambda 3) protein, human; interleukin 28B protein, human; interleukin 28B, human; interleukin 29 (interferon, lambda 1) protein, human; interleukin 29 protein, human; interleukin 29, human

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Constant, Samuel: 1 article (06/2021)
2.	Huang, Song: 1 article (06/2021)
3.	Medaglia, Chiara: 1 article (06/2021)
4.	Silva, Paulo Jacob: 1 article (06/2021)
5.	Stellacci, Francesco: 1 article (06/2021)
6.	Tapparel, Caroline: 1 article (06/2021)
7.	Zwygart, Arnaud Charles-Antoine: 1 article (06/2021)
8.	Alavian, Seyed Moayed: 1 article (07/2017)
9.	Behnava, Bita: 1 article (07/2017)
10.	Craig, Johanna C: 1 article (07/2017)

Related Diseases

1.	Chronic Hepatitis C 07/01/2017 - "The aim of this study was to determine whether two polymorphisms of the human interferon lambda 4 (IFNL4) gene (rs12979860 and rs8099917) can predict sustained virologic response (SVR) following antiviral therapy in patients with inherited bleeding disorder and chronic hepatitis C (CHC). "
2.	Hemorrhage 07/01/2017 - "The aim of this study was to determine whether two polymorphisms of the human interferon lambda 4 (IFNL4) gene (rs12979860 and rs8099917) can predict sustained virologic response (SVR) following antiviral therapy in patients with inherited bleeding disorder and chronic hepatitis C (CHC). "
3.	Infections 06/01/2021 - "Using an in vitro infection model, we assessed the barrier to viral resistance of a combination therapy with the neuraminidase inhibitor oseltamivir and human interferon lambda against the pandemic H1N1 A/Netherlands/602/2009 (H1N1pdm09) virus. "

Related Drugs and Biologics

1.	Antiviral Agents (Antivirals)
2.	Oseltamivir (Tamiflu)
3.	Neuraminidase (Sialidase)

Related Therapies and Procedures

1.	Therapeutics